A critical component of the biopharmaceutical development process is the creation of a formulation to protect proteins from various mechanical and thermal stressors that occur during manufacturing, storage and transport. In non-optimized formulations, stressors cause protein degradation which can render the biopharmaceutical ineffective and possibly harmful to patients. For this reason, researchers are starting to...Read More
Earlier this month Louisiana Economic Development (LED) and the U.S Small Business Administrationhonored leaders advancing Louisiana’s business climate. Fluence Analytics, a manufacturer of realtime monitoring systems for polymer and biopharmaceutical companies, received the Most Outstanding Business Growth Award. “LED has played an important role in the overall success of Fluence Analytics. LED has provided many resources and tools that...Read More
Fluence Analytics CSO, Prof. Wayne Reed, and Strategic Advisor, Bernhard Bartylla, are representing the company at the 30th International Symposium on Polymer Analysis and Characterization (ISPAC). ISPAC 2017 takes place from June 11-14, 2017 at Johannes Kepler University in Linz, Austria. Prof. Reed, who is also Chair of ISPAC for the Americas, is presenting results on the...Read More
In April 2017, The Frontier held its inaugural conference in New Orleans, attracting hundreds of entrepreneurs and business leaders from across the United States. The Frontier brought together individuals from diverse industry backgrounds to engage in discussions of new ideas, technology, innovation, long-term vision, and interdisciplinary collaborative opportunities to shatter current barriers and revolutionize the world’s largest industries....Read More
Fluence Analytics launched its Applications Engineering Center during summer 2016. Working directly with customers and conducting internal R&D, Fluence Analytics has used ACOMP to monitor, and in some cases control, numerous polymerizations across a spectrum of polymer families. Since the launch of the Center, Fluence Analytics has expanded the number of polymer chemistries which are...Read More
(New Orleans, LA, U.S.) ‒ Fluence Analytics, formerly Advanced Polymer Monitoring Technologies (APMT), announced today it has raised a Series A financing round led by Energy Innovation Capital (EIC), a venture capital firm that invests in growing companies in energy innovation. Fluence Analytics products optimize efficiency, cost and quality of manufacturing and R&D processes in...Read More
(New Orleans, LA, U.S.) ‒ Advanced Polymer Monitoring Technologies today announced a comprehensive rebrand and a name change to Fluence Analytics. Fluence Analytics provides proprietary hardware and software products for the industrial and laboratory monitoring of polymer and biopharmaceutical manufacturing processes and R&D applications. The company’s patented technologies improve production efficiency and quality as well...Read More
The Industrial Internet of Things (IIoT) and smart manufacturing initiatives are accelerating the creation of new technologies, transforming global manufacturing. Like most innovation, competitive advantage and measurable, improved economics will be the biggest drivers of adoption. Enhanced sensors, data collection, analysis, visualization and interpretation will drive accelerated learning from existing processes and inform the design...Read More
APMT Research Engineer Natalie Leonardi is making a presentation on Automatic Control of Polymer Molecular Weight during a Free Radical Polymerization at the 2017 AIChE Spring Meeting and 13th Global Congress on Process Safety. The Spring Meeting is taking place in San Antonio, TX at the Henry B. Gonzalez Convention Center, and Natalie’s talk is...Read More
Biopharmaceutical companies isolate many types of proteins for use in experimental and therapeutic medicines. Unfortunately, when removed from their native environments, proteins become less stable. Unstable proteins are more prone to degradation from the primary stress mechanisms: mechanical and thermal (from manufacturing, storage and transport) and biological (from drug delivery). The challenge for biopharmaceutical companies...Read More
